Monthly Factsheet- June 2025
 |
Geiger Counter Limited Plc
Monthly Investor Report 23 July 2025
(All Factsheet data is at 30 June 2025)
The full monthly factsheet is now available on the Company's website and a summary can be found below.
NCIM - Geiger Counter Ltd - Fund Page for Geiger Counter Ltd
Enquiries:
For the Investment Manager
Craig Cleland
Manulife CQS Investment Management
0207 201 5368
For the Company Secretary and Administrator
R&H Fund Services (Jersey) Limited
Jane De Barros/Katie De La Cour
01534 825259/01534 825337
-----------------------------------------------------------------------
Fund Description
The objective of Geiger Counter Limited is to provide investors with the potential for capital growth through investment primarily in the securities of companies involved in the exploration, development and production of energy, predominantly within the uranium industry. Up to 30% of the value of the Company's investment portfolio may be invested in other resource- related companies from outside the energy sector.
Portfolio Managers
Keith Watson and Robert Crayfourd
Key Advantages for the Investor
· Access to mining assets in the uranium sector
· May benefit from embedded subscription share
· Low correlation to major asset classes
Key Fund Facts1
|
Total Gross Assets |
£71.7m |
|
Reference Currency |
GBP |
|
Ordinary Shares: |
|
|
Net Asset Value |
50.31 |
|
Mid-Market Price |
43.80p |
|
Net gearing4 |
21.50% |
|
Discount |
(12.94%) |
Ordinary Share and NAV Performance2
|
|
One Month |
Three Months |
One Year |
Three Years |
Five Years |
|
|
(%) |
(%) |
(%) |
(%) |
(%) |
|
NAV |
18.35 |
46.72 |
(20.10) |
23.98 |
238.10 |
|
Share Price |
9.50 |
29.97 |
(11.52) |
10.19 |
171.21 |
Commentary3
The Company's NAV rose 18.4% over the month against a stronger uranium price backdrop. The spot U3O8 price ended the month up 3.7% at $74.3/lb with support arising after a $200m equity placement by the Sprott Physical Uranium Trust for the purpose of acquiring more material. The Company's return compared to a sterling gain of 18.0% registered by the Solactive Uranium Pure Play Index.
Early in the month, first Meta and then Amazon announced that they had formalised long-term
nuclear power purchase agreements with Constellation Energy and Talen Energy respectively to power their data centres, helping buoy sentiment. Subsequently, the Sprott Uranium Trust
continued to buy uranium, funded by its upsized equity issue which allowed it to purchase nearly 1.5Mlbs of U3O8 during June, taking its total holding towards 68Mlbs by the end of the month.
Nexgen made a strong contribution to performance with the share price rising nearly 12% in June. Encouragingly, the incoming and pro-nuclear Canadian government held a conference among its top ministers to assess projects of national strategic importance. This included energy and critical minerals, a move which would appear supportive for the future development of Nexgen's globally significant Arrow project in Saskatchewan. The development is awaiting its final court hearings, currently scheduled to take place in early 2026. Elsewhere, Ur-Energy also made a strong contribution, with the shares rising over 28% over the month, as the group continues to ramp-up production from the restarting Lost Creek ISR Project. Paladin and Cameco were also helpful with their share prices rising 29% and 26% respectively.
|
|
Gross Leverage6 (%) |
Commitment Leverage7 (%) |
|
Geiger Counter Ltd |
122 |
122 |
CQS (UK) LLP
4th Floor, One Strand, London WC2N 5HR, United Kingdom
T: +44 (0) 20 7201 6900 | F: +44 (0) 20 7201 1200
CQS (US), LLC
152 West 57th Street, 40th Floor, New York, NY 10019, US
T: +1 212 259 2900 | F: +1 212 259 2699
Tavistock Communications
18 St. Swithin's Lane, London EC4N 8AD
T: +44 20 7920 3150 | geigercounter@tavistock.co.uk
Sources: 1R&H Fund Services (Jersey) Limited, as at the last business day of the month indicated at the top of this report. 2R&H Fund Services Limited/DataStream, as at the last business day of the month indicated at the top of this report, total return performance net of fees and expenses based on bid prices. These include historic returns and past performance is not a reliable indicator of future results. The value of investments can go down as well as up. Please read the important legal notice at the end of this document. 3Market data sourced from Bloomberg unless otherwise stated. The Fund may since have exited some or all of the positions detailed in the commentary. 4 BMO, UxC, Company data September 2023. 5 www.eia.gov. 6CQS, as at the last business day of the month indicated at the top of this report. For methodology details see Article 4(3) of Directive 2011/61/EU (AIFMD) and Articles 6, 7, 9 and 10 of Delegated Regulation 231/2013. 7CQS, as at the last business day of the month indicated at the top of this report. For methodology details see Article 4(3) of Directive 2011/61/EU (AIFMD) and Articles 6, 8, 9, 10 and 11 of Delegated Regulation 231/2013.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 6 hours ago Luceco
- 6 hours ago Helios Towers
- 6 hours ago Wise Class A
- 6 hours ago EDX Medical Group Plc
- 7 hours ago Naked Wines